Virology
The last twenty years has seen an explosion in the rate of discovery of new agents to treat diseases caused by viral infections. Technological advances have driven the discovery of new viruses associated with significant human diseases and a molecular understanding of processes by which disease-causing viruses infect and replicate in human cells. The result of these advances has been the development of many new classes of antiviral drugs for viral infections where no specific antiviral therapy had previously existed and where classical vaccination approaches have failed.
The development of effective treatments for viral infections is a significant scientific challenge. At our R&D centre the focus of virology research is on viruses responsible for very serious human diseases where current treatments are lacking and there is an opportunity to develop novel and innovative therapies to improve patient outcomes. Currently, virology research in Laval is focused on developing new treatments for diseases caused by:
